Furthermore, the review explores key clinical factors influencing cancer risk associated with GLP-1RAs, such as patient population characteristics and medication regimens
GLP-1 and GIP-based therapies may be appropriate for individuals with Type 2 diabetes, insulin resistance, or those who are overweight (BMI 2730+) with at least one weight-related condition such as high blood pressure, high cholesterol, sleep apnea, or cardiovascular disease
Here are foods to limit and what to prioritize
PlexusDx also offers the Precision Peptide Genetic Test ($99 add-on after first month of treatment), which identifies genetic variations in appetite regulation, metabolic pathways, and peptide sensitivity to optimize your specific treatment protocol
Doctors typically prescribe phentermine for short-term use, usually ranging from a few weeks to a few months
Permission to use cookies By accessing this website with your browser, this means that you accept cookies and that you agree to their use